Data as of .
GNMX vs GNOM: which is really different?
GNMX and GNOM hold 47% of their weight in the same names.
ETFIQ Off-Index Score: GNMX scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
47% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, GNMX and GNOM hold 47% of their money in the same securities at the same weight.
| Holding | GNMX | GNOM |
|---|---|---|
| Moderna Inc | 7.05% | 7.99% |
| Illumina Inc | 4.36% | 5.30% |
| Guardant Health Inc | 3.86% | 5.78% |
| 10X Genomics Inc | 3.42% | 6.53% |
| Vertex Pharmaceuticals Inc | 5.89% | 3.35% |
| Twist Bioscience Corp | 2.86% | 7.40% |
| BioMarin Pharmaceutical Inc | 2.22% | 3.41% |
| Bio-Techne Corp | 2.20% | 3.56% |
| QIAGEN NV | 1.86% | 3.13% |
| uniQure NV | 1.65% | 1.84% |
| CareDx Inc | 1.60% | 1.85% |
| Arrowhead Pharmaceuticals Inc | 1.50% | 2.59% |
| Only in GNMX | Only in GNOM |
|---|---|
| Thermo Fisher Scientific Inc 8.62% | NATERA INC 5.13% |
| Revolution Medicines Inc 3.27% | GENSCRIPT BIOTECH CORP 4.29% |
| Genmab A/S 2.91% | PRAXIS PRECISION MEDICINES I 2.56% |
| Incyte Corp 2.90% | BIONTECH SE-ADR 2.55% |
| Alnylam Pharmaceuticals Inc 2.64% | LEGEND BIOTECH CORP-ADR 1.96% |
| First American Government Obligations Fu 2.62% | ELI LILLY & CO 1.79% |
| Iovance Biotherapeutics Inc 2.30% | GILEAD SCIENCES INC 1.63% |
| Tempus AI Inc 2.02% | BILLIONTOONE INC CL A 1.58% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 18, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| GNMX | GNOM | GNMX | GNOM | GNMX | GNOM | |
| 3 months | +29.7% | +27.6% | +27.4 pts | +25.4 pts | +32.2 pts | +30.1 pts |
| 6 months | not published | +56.4% | not published | +38.4 pts | not published | +32.2 pts |
| 1 year | not published | +77.5% | not published | +60.9 pts | not published | +55.7 pts |
| 3 years | not published | +59.3% | not published | −19.1 pts | not published | −38.9 pts |
| Since launch | +41.2% | +9.8% | +36.9 pts | −185.2 pts | +37.4 pts | −297.4 pts |
| GNMX Corgi Genomics & Precision Medicine ETF Holds 58 stocks in genomics and gene editing, 27% of its weight in S&P 500 companies | GNOM Global X Genomics & Biotechnology ETF Holds 52 stocks in genomics and gene editing, 21% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Corgi | Global X |
| Theme | Genomics and gene editing | Genomics and gene editing |
| In the S&P 500 | 26.7% | 20.9% |
| Active share vs the S&P 500 | 99.4% | 97.6% |
| In the Nasdaq-100 | 8.5% | 5.0% |
| Holdings | 58 | 52 |
| Top ten, share of the fund | 45.1% | 52.7% |
| Expense ratio | 0.35% | 0.50% |
| Fee for the differing part | 0.35% | 0.51% |
| Total return, 1 year | +41.2% (since launch on May 6, 2026) | +77.5% |
| vs the S&P 500 | +36.9 pts | +60.9 pts |
| vs the Nasdaq-100 | +37.4 pts | +55.7 pts |
| Below its high | −1.0% | −39.6% |
| Net assets | $3m | $100m |
GNMX in plain words
By weight, 27% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 45% of the fund across 58 positions, as published by its issuer for Sep 18, 2026. Since it launched on May 6, 2026 the fund returned +41.2% with distributions reinvested against +4.3% for the S&P 500, so a holder was ahead by 36.9 pts.
GNOM in plain words
By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 53% of the fund across 52 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +77.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 60.9 pts. It sits 39.6% below its all-time high of Feb 8, 2021.
Questions people ask
- Do GNMX and GNOM hold the same stocks?
- By their latest filings, 47% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, GNMX or GNOM?
- GNMX has 27% of its weight in S&P 500 names and GNOM has 21%, so GNMX differs more from the index.
- Which is cheaper, GNMX or GNOM?
- GNMX charges 0.35% a year and GNOM charges 0.50%, so GNMX is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, GNMX against GNOM, data as of Sep 18, 2026. https://etfiq.com/compare/themes/gnmx-vs-gnom Free to use with attribution; the underlying files are at Open data.